|
Hong Kong Pharmaceuticals News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about Hong Kong Pharmaceuticals.
Latest Hong Kong Pharmaceuticals News
- ChromaDex Raises $1 Million Capital in Private Placement Transaction 6 Dec 2009 15:41 GMT
... a securities purchase agreement with Jinke Group (Hong Kong) Ltd., under which Jinke has agreed to ... to the functional food, cosmetic, dietary supplement, pharmaceutical / life sciences and other industries." ChromaDex ...
- Helicobacter pylori Therapy: Study findings from University of Hong Kong, Department of Medicine provide new insights into helicobacter pylori therapy 1 Dec 2009 05:54 GMT
... valid empirical first-line treatment for eradication in Hong Kong,' new data in helicobacter pylori. "Recent studies ... Inhibitor, Esomeprazole, Gastroenterology, Helicobacter, Infectious Disease, Levofloxacin, Pharmaceuticals, Proton-Pump Inhibitor, Therapy, Treatment. This article was ...
- AlphaRx Establishes Corporate Headquarters in Hong Kong and R&D Facility in Shanghai 3 Dec 2009 13:40 GMT
... AlphaRx Establishes Corporate Headquarters in Hong Kong and R&D Facility in Shanghai AlphaRx Establishes ... will be located in The State Biotech Pharmaceutical industrial base (Shanghai) which is situated on ...
- AlphaRx Establishes Corporate Headquarters in Hong Kong and R&D Facility in Shanghai (PRN) 3 Dec 2009 13:34 GMT
... AlphaRx Establishes Corporate Headquarters in Hong Kong and R&D Facility in Shanghai (OTCBB: ALRX), ... will be located in The State Biotech Pharmaceutical industrial base (Shanghai) which is situated on ...
- Pharmasset Reports Fiscal Year End 2009 Financial Results 1 Dec 2009 14:31 GMT
... Pharmasset Reports Fiscal Year End 2009 Financial Results ... under the trade name Levovir, and in Hong Kong, where clinical studies were being conducted under ...
- Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3 Dec 2009 10:51 GMT
... NANJING, China, Dec. 3 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: ), ... Ruirui Jiang Brunswick Group Tel: +86-10-6566-2256 In Hong Kong: Joseph Lo Chi-Lun Brunswick Group Tel: +852-3512-5000 ...
- Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical Testing and Government Reimbursement for Its O 3 Dec 2009 19:35 GMT
... Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical ... These markets include Latin America, Taiwan, China, Hong Kong, Asia-Pacific, Europe and Israel. For FY2010 in ...
- Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical Testing and Government Rei 3 Dec 2009 20:10 GMT
... Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical ... These markets include Latin America, Taiwan, China, Hong Kong, Asia-Pacific, Europe and Israel. For FY2010 in ...
- Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical Testing and Government Reimbursement for Its Onko-Sure(TM) in Vitro Diagnostic Cancer Test 3 Dec 2009 19:30 GMT
... Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical ... These markets include Latin America, Taiwan, China, Hong Kong, Asia-Pacific, Europe and Israel. For FY2010 in ...
- Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen (PRN) 3 Dec 2009 10:55 GMT
... applicable law. (NYSE:SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and ... United States: Kate Tellier Tel: +86-10-6566-2256 In Hong Kong: Joseph Lo Chi-Lun ...
- Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2 Dec 2009 11:11 GMT
... Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of ... Kate Tellier Brunswick Group Tel: +1-212-333-3810 In Hong Kong: Joseph Lo Chi-Lun Brunswick Group Tel: +852-3512-5000 ...
- Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical Testing and Government Reimbursement for Its Onko-Sure(TM) in Vitro Diagnostic Cancer Test (MRW) 3 Dec 2009 19:35 GMT
... Based upon Radient Pharmaceutical's 5-year product sales projections, the Company anticipates ... These markets include Latin America, Taiwan, China, Hong Kong, Asia-Pacific, Europe and Israel. For FY2010 in ...
- Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production (PRN) 2 Dec 2009 11:15 GMT
... applicable law. (NYSE:SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and ... United States: Kate Tellier Tel: +1-212-333-3810 In Hong Kong: Joseph Lo Chi-Lun ...
- Indian shares up 0.9 pct; autos rally 1 Dec 2009 07:04 GMT
... MUMBAI, Dec 1 (Reuters) - Indian shares were ... was up nearly 1 percent at * Drug maker Cipla rose 3.3 percent to 330.70 rupees. ... in talks with a host of global drug makers, including Pfizer Inc, to supply generic products, ...
- JST, BRGO, LSGGF, LCPM, HTHKY, DCGN Have Been Added To Naked Short Lists Today 1 Dec 2009 05:36 GMT
... deliver in shares of LCPM. Hutchison Telecommunications Hong Kong Holdings Limited (OTC: HTHKY) and its subsidiaries ... HTHKY. deCODE genetics, Inc. (NASDAQ: DCGN), a bio-pharmaceutical company, develops and markets products for the ...
- Dow Jones Indexes Announces Dow Jones Select Dividend and Dow Jones Country Titans Indexes Regular Annual and Quarterly Review Results 4 Dec 2009 00:32 GMT
... Jones Asia Select Dividend 30, Dow Jones Hong Kong Select Dividend 30 and Dow Jones Country ... 4523.TO), Emera Inc. (Canada, Utilities, EMA.T), Ono Pharmaceutical Co. Ltd. (Japan, Health Care, 4528.OK), Bouygues ...
- Dow Jones Indexes Announces Dow Jones Select Dividend and Dow Jones Country Titans Indexes Regular A 4 Dec 2009 00:58 GMT
... Jones Asia Select Dividend 30, Dow Jones Hong Kong Select Dividend 30 and Dow Jones Country ... 4523.TO), Emera Inc. (Canada, Utilities, EMA.T), Ono Pharmaceutical Co. Ltd. (Japan, Health Care, 4528.OK), Bouygues ...
- Dow Jones Indexes Announces Dow Jones Select Dividend and Dow Jones Country Titans Indexes Regular Annual and Quarterly Review Results 4 Dec 2009 01:36 GMT
... 4523.TO), Emera Inc. (Canada, Utilities, EMA.T), Ono Pharmaceutical Co. Ltd. (Japan, Health Care, 4528.OK), Bouygues ... Industrial & Commercial Bank of China (Asia) (Hong Kong, Banks, 0349.HK), BT Group PLC (Great Britain, ...
- Dow Jones Indexes Announces Dow Jones Select Dividend and Dow Jones Country Titans Indexes Regular A 4 Dec 2009 01:40 GMT
... Jones Asia Select Dividend 30, Dow Jones Hong Kong Select Dividend 30 and Dow Jones Country ... 4523.TO), Emera Inc. (Canada, Utilities, EMA.T), Ono Pharmaceutical Co. Ltd. (Japan, Health Care, 4528.OK), Bouygues ...
- Dow Jones Indexes Announces Dow Jones Select Dividend and Dow Jones Country Titans Indexes Regular Annual and Quarterly 4 Dec 2009 01:42 GMT
... Jones Asia Select Dividend 30, Dow Jones Hong Kong Select Dividend 30 and Dow Jones Country ... 4523.TO), Emera Inc. (Canada, Utilities, EMA.T), Ono Pharmaceutical Co. Ltd. (Japan, Health Care, 4528.OK), Bouygues ...
- Dow Jones Select Dividend And Dow Jones Country Titans Indexes Regular Annual And Quarterly Review Results 4 Dec 2009 06:55 GMT
... Jones Asia Select Dividend 30, Dow Jones Hong Kong Select Dividend 30 and Dow Jones Country ... 4523.TO), Emera Inc. (Canada, Utilities, EMA.T), Ono Pharmaceutical Co. Ltd. (Japan, Health Care, 4528.OK), Bouygues ...
- CCH Honors Leaders and Innovators of the HR Industry at its 12th Annual Human Resources Awards 4 Dec 2009 11:19 GMT
... respective companies." First held in 1998 in Hong Kong, the China STAFF HR Awards expanded to ... and sustainable growth. Jennifer Jin of Novartis Pharma China won the "HR Director of the Year" ...
- Incurable `Orphan - Disease' could affect hundreds 3 Dec 2009 20:31 GMT
... could affect hundreds Hundreds of children in Hong Kong could be suffering from a rare, difficult ... But they have been abandoned by the pharmaceutical companies - who deem it too expensive ...
- HK, China shares up; Geely at record high 2 Dec 2009 06:00 GMT
... * Hong Kong market up 1.28 pct on Wall Street ... holds a positive view towards the property, pharmaceutical and coal sectors. ChiNext <0#CHINEXT.SZ>, China's Nasdaq-style ...
- Buchang Global Health Forum 2009: An Innovative Approach for Management of H1N1 Swine Flu 3 Dec 2009 18:12 GMT
... the virus have emerged recently in Norway, Hong Kong and the USA. Buchang USA Inc. together ... and controlled through international collaboration of medical, pharmaceutical, and educational resources." Dr. Yang Xu, a ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Pharmaceutical Industry Today
|
a digital news provider
ap.org:
cnn.com:
bbc.co.uk:
healthday.com: